Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic Dermatitis

NCT04462055 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT04462055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04462055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic Dermatitis
Lead sponsor
UMC Utrecht
Phase
Observational
Overall status
Terminated
Start date
May 1, 2019
Completion date
July 1, 2022
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

food allergy